Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.41

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.24

Views

Views
March 20254
April 20254
May 20251
June 20250
July 202515
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
Singapore4
United States3
United Kingdom3
Austria1
Spain1
Hong Kong1
Morocco1
Senegal1
 

Top cities views

Views
São Paulo2
Ashton-under-Lyne1
Belo Horizonte1
Billingshurst1
Council Bluffs1
Dakar1
Gracilândia1
Hong Kong1
João Pessoa1
Mandeville1